| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urea Cycle Disorders, Inborn | 9 | 2025 | 84 | 3.160 |
Why?
|
| Intellectual Disability | 17 | 2024 | 1048 | 2.110 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 6 | 2023 | 113 | 2.070 |
Why?
|
| Osteochondrodysplasias | 3 | 2019 | 66 | 1.450 |
Why?
|
| Argininosuccinate Lyase | 3 | 2021 | 65 | 1.420 |
Why?
|
| Genetic Association Studies | 7 | 2024 | 808 | 1.400 |
Why?
|
| Lipid Metabolism, Inborn Errors | 4 | 2025 | 25 | 1.280 |
Why?
|
| Phenotype | 29 | 2024 | 4304 | 1.240 |
Why?
|
| Mutation | 17 | 2024 | 5941 | 1.220 |
Why?
|
| Developmental Disabilities | 12 | 2026 | 718 | 1.210 |
Why?
|
| Growth Disorders | 3 | 2023 | 183 | 1.080 |
Why?
|
| Genetic Diseases, Inborn | 5 | 2025 | 459 | 1.050 |
Why?
|
| Child, Preschool | 37 | 2026 | 14347 | 1.030 |
Why?
|
| Lung Diseases | 3 | 2021 | 395 | 1.020 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2024 | 155 | 1.020 |
Why?
|
| Heterozygote | 7 | 2025 | 690 | 1.010 |
Why?
|
| Chromosome Deletion | 5 | 2018 | 642 | 1.010 |
Why?
|
| Liver Diseases | 2 | 2021 | 381 | 0.990 |
Why?
|
| Liver Cirrhosis | 2 | 2025 | 875 | 0.980 |
Why?
|
| Metabolism, Inborn Errors | 4 | 2022 | 119 | 0.970 |
Why?
|
| Ectodermal Dysplasia | 2 | 2024 | 47 | 0.920 |
Why?
|
| Collagen Type II | 2 | 2016 | 23 | 0.910 |
Why?
|
| Microcephaly | 3 | 2022 | 343 | 0.900 |
Why?
|
| Amino Acid Transport System y+L | 2 | 2023 | 17 | 0.870 |
Why?
|
| Propionic Acidemia | 2 | 2022 | 10 | 0.830 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2014 | 72 | 0.830 |
Why?
|
| Child | 45 | 2026 | 25101 | 0.820 |
Why?
|
| Fatty Liver | 2 | 2025 | 204 | 0.810 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 3 | 2025 | 27 | 0.810 |
Why?
|
| Genetic Variation | 7 | 2022 | 1508 | 0.790 |
Why?
|
| Hyperammonemia | 5 | 2023 | 60 | 0.770 |
Why?
|
| Autism Spectrum Disorder | 3 | 2023 | 423 | 0.760 |
Why?
|
| Argininosuccinic Aciduria | 4 | 2025 | 55 | 0.740 |
Why?
|
| Muscular Diseases | 3 | 2022 | 116 | 0.730 |
Why?
|
| Craniosynostoses | 1 | 2024 | 139 | 0.720 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 316 | 0.710 |
Why?
|
| Filamins | 2 | 2021 | 27 | 0.710 |
Why?
|
| Aniridia | 1 | 2021 | 11 | 0.700 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 33 | 0.690 |
Why?
|
| Humans | 87 | 2026 | 126754 | 0.680 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 69 | 0.660 |
Why?
|
| Muscle Hypotonia | 7 | 2023 | 188 | 0.660 |
Why?
|
| Phenylbutyrates | 3 | 2023 | 55 | 0.650 |
Why?
|
| Diet | 7 | 2015 | 1100 | 0.650 |
Why?
|
| Dwarfism | 3 | 2015 | 102 | 0.650 |
Why?
|
| Introns | 1 | 2021 | 281 | 0.650 |
Why?
|
| Liver Glycogen | 1 | 2020 | 22 | 0.650 |
Why?
|
| Liver Transplantation | 5 | 2025 | 1105 | 0.640 |
Why?
|
| Liver | 2 | 2025 | 1765 | 0.640 |
Why?
|
| Female | 60 | 2026 | 68330 | 0.640 |
Why?
|
| Pneumonectomy | 1 | 2021 | 149 | 0.640 |
Why?
|
| Exome | 11 | 2023 | 1064 | 0.600 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 2 | 2015 | 12 | 0.600 |
Why?
|
| Male | 55 | 2026 | 62543 | 0.600 |
Why?
|
| Micrognathism | 3 | 2017 | 65 | 0.590 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 58 | 0.590 |
Why?
|
| Adolescent | 28 | 2026 | 20002 | 0.590 |
Why?
|
| Carnitine | 4 | 2025 | 68 | 0.580 |
Why?
|
| Phenylketonurias | 2 | 2023 | 15 | 0.580 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 63 | 0.570 |
Why?
|
| Alleles | 8 | 2021 | 1609 | 0.570 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2025 | 3262 | 0.560 |
Why?
|
| Congenital Abnormalities | 2 | 2018 | 300 | 0.560 |
Why?
|
| Fibroblasts | 8 | 2024 | 819 | 0.550 |
Why?
|
| Seizures | 9 | 2023 | 847 | 0.550 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2018 | 138 | 0.550 |
Why?
|
| Metabolomics | 2 | 2019 | 455 | 0.550 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2017 | 5 | 0.540 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2025 | 899 | 0.540 |
Why?
|
| Chromosomes, Mammalian | 5 | 2011 | 41 | 0.540 |
Why?
|
| Biomarkers | 4 | 2021 | 3222 | 0.540 |
Why?
|
| Larynx | 1 | 2018 | 72 | 0.530 |
Why?
|
| Infant | 23 | 2024 | 12771 | 0.530 |
Why?
|
| Quantitative Trait Loci | 9 | 2025 | 290 | 0.530 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2022 | 422 | 0.520 |
Why?
|
| Mitochondrial Diseases | 2 | 2015 | 145 | 0.520 |
Why?
|
| DNA-Binding Proteins | 6 | 2023 | 1877 | 0.520 |
Why?
|
| Young Adult | 18 | 2026 | 9665 | 0.510 |
Why?
|
| NF-kappa B | 1 | 2019 | 438 | 0.510 |
Why?
|
| Hip Joint | 1 | 2016 | 50 | 0.500 |
Why?
|
| Chromosome Disorders | 1 | 2018 | 315 | 0.490 |
Why?
|
| Geminin | 1 | 2015 | 7 | 0.480 |
Why?
|
| Tibial Fractures | 1 | 2016 | 64 | 0.480 |
Why?
|
| DNA Damage | 1 | 2019 | 498 | 0.480 |
Why?
|
| Patella | 1 | 2015 | 27 | 0.480 |
Why?
|
| Hyperargininemia | 1 | 2015 | 13 | 0.480 |
Why?
|
| Arginase | 1 | 2015 | 35 | 0.470 |
Why?
|
| Neonatal Screening | 5 | 2025 | 190 | 0.460 |
Why?
|
| DNA Copy Number Variations | 4 | 2024 | 1004 | 0.460 |
Why?
|
| Fractures, Bone | 1 | 2017 | 191 | 0.460 |
Why?
|
| Congenital Microtia | 1 | 2015 | 26 | 0.460 |
Why?
|
| Pedigree | 9 | 2024 | 1656 | 0.460 |
Why?
|
| Obesity | 7 | 2012 | 2332 | 0.450 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2015 | 39 | 0.450 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2026 | 526 | 0.450 |
Why?
|
| Respiratory Insufficiency | 1 | 2017 | 236 | 0.440 |
Why?
|
| Disease Models, Animal | 9 | 2023 | 4429 | 0.440 |
Why?
|
| Muscle Proteins | 1 | 2017 | 398 | 0.440 |
Why?
|
| Anemia, Sideroblastic | 1 | 2014 | 15 | 0.430 |
Why?
|
| Mitochondrial Myopathies | 1 | 2014 | 28 | 0.430 |
Why?
|
| Fasting | 1 | 2015 | 300 | 0.430 |
Why?
|
| Mutation, Missense | 9 | 2025 | 891 | 0.430 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2014 | 14 | 0.430 |
Why?
|
| Animals | 32 | 2026 | 33051 | 0.430 |
Why?
|
| Acidosis, Lactic | 1 | 2014 | 29 | 0.430 |
Why?
|
| Mice | 23 | 2023 | 17596 | 0.420 |
Why?
|
| Kidney | 1 | 2020 | 1283 | 0.410 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 535 | 0.410 |
Why?
|
| Trisomy | 2 | 2012 | 107 | 0.410 |
Why?
|
| Scleroderma, Systemic | 2 | 2025 | 127 | 0.400 |
Why?
|
| Sequence Analysis, RNA | 3 | 2025 | 416 | 0.400 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2017 | 234 | 0.390 |
Why?
|
| Arginine | 1 | 2015 | 335 | 0.390 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 233 | 0.390 |
Why?
|
| Lung Transplantation | 1 | 2017 | 344 | 0.390 |
Why?
|
| Adult | 22 | 2026 | 30410 | 0.380 |
Why?
|
| Uniparental Disomy | 1 | 2012 | 40 | 0.380 |
Why?
|
| Rare Diseases | 2 | 2020 | 201 | 0.370 |
Why?
|
| T-Box Domain Proteins | 1 | 2013 | 110 | 0.370 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 452 | 0.370 |
Why?
|
| Genetics, Medical | 2 | 2023 | 116 | 0.370 |
Why?
|
| Prader-Willi Syndrome | 1 | 2012 | 62 | 0.360 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2012 | 143 | 0.360 |
Why?
|
| Mosaicism | 1 | 2013 | 230 | 0.350 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2023 | 576 | 0.340 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 319 | 0.340 |
Why?
|
| Exons | 5 | 2022 | 757 | 0.340 |
Why?
|
| Infant, Newborn | 15 | 2025 | 8347 | 0.340 |
Why?
|
| Epilepsy, Generalized | 2 | 2021 | 61 | 0.320 |
Why?
|
| Trans-Activators | 1 | 2013 | 675 | 0.310 |
Why?
|
| Oxidative Phosphorylation | 2 | 2025 | 126 | 0.300 |
Why?
|
| Mice, Knockout | 3 | 2023 | 3709 | 0.300 |
Why?
|
| Leukoencephalopathies | 2 | 2020 | 60 | 0.300 |
Why?
|
| Bone and Bones | 2 | 2021 | 294 | 0.300 |
Why?
|
| Limb Deformities, Congenital | 2 | 2024 | 109 | 0.290 |
Why?
|
| Abnormalities, Multiple | 4 | 2024 | 964 | 0.290 |
Why?
|
| Amino Acid Sequence | 6 | 2020 | 2541 | 0.270 |
Why?
|
| Genes, Dominant | 2 | 2020 | 241 | 0.270 |
Why?
|
| Autistic Disorder | 2 | 2021 | 363 | 0.270 |
Why?
|
| Genotype | 7 | 2019 | 2595 | 0.270 |
Why?
|
| Transcription Factors | 4 | 2023 | 2337 | 0.260 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 781 | 0.250 |
Why?
|
| Caenorhabditis elegans | 6 | 2025 | 228 | 0.250 |
Why?
|
| Base Sequence | 5 | 2023 | 2757 | 0.250 |
Why?
|
| Syndrome | 5 | 2024 | 1137 | 0.240 |
Why?
|
| Catatonia | 1 | 2026 | 17 | 0.240 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2025 | 5 | 0.230 |
Why?
|
| Nuclear Proteins | 3 | 2022 | 1204 | 0.230 |
Why?
|
| Phospholipase C gamma | 1 | 2025 | 28 | 0.230 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2023 | 95 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 9 | 2023 | 4504 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2018 | 362 | 0.230 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 3584 | 0.230 |
Why?
|
| Cells, Cultured | 4 | 2020 | 2893 | 0.220 |
Why?
|
| Hand Deformities, Congenital | 2 | 2017 | 95 | 0.220 |
Why?
|
| Craniofacial Abnormalities | 2 | 2019 | 252 | 0.220 |
Why?
|
| Vision, Ocular | 1 | 2025 | 124 | 0.220 |
Why?
|
| Interferons | 1 | 2025 | 133 | 0.220 |
Why?
|
| Nervous System Diseases | 2 | 2025 | 393 | 0.210 |
Why?
|
| Psychotic Disorders | 1 | 2026 | 151 | 0.210 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2024 | 49 | 0.210 |
Why?
|
| Zebrafish | 3 | 2026 | 402 | 0.210 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2024 | 49 | 0.210 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1428 | 0.210 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 58 | 0.200 |
Why?
|
| Retrospective Studies | 11 | 2023 | 17005 | 0.200 |
Why?
|
| Siblings | 1 | 2024 | 202 | 0.200 |
Why?
|
| Prevalence | 2 | 2025 | 2591 | 0.200 |
Why?
|
| Radiography | 2 | 2016 | 752 | 0.190 |
Why?
|
| Inheritance Patterns | 2 | 2015 | 129 | 0.190 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 2022 | 4 | 0.190 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2022 | 5 | 0.190 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2022 | 11 | 0.190 |
Why?
|
| Transposases | 1 | 2022 | 40 | 0.190 |
Why?
|
| Epileptic Syndromes | 1 | 2022 | 36 | 0.190 |
Why?
|
| Middle Aged | 8 | 2025 | 27697 | 0.180 |
Why?
|
| F-Box Proteins | 1 | 2022 | 32 | 0.180 |
Why?
|
| Calcium Channels, R-Type | 1 | 2021 | 2 | 0.180 |
Why?
|
| Machine Learning | 1 | 2025 | 325 | 0.180 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2010 | 103 | 0.180 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 14 | 0.180 |
Why?
|
| Biopsy | 1 | 2025 | 1236 | 0.180 |
Why?
|
| Coatomer Protein | 1 | 2021 | 30 | 0.180 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2023 | 167 | 0.180 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 111 | 0.170 |
Why?
|
| Syndactyly | 1 | 2021 | 24 | 0.170 |
Why?
|
| Protein Precursors | 1 | 2022 | 144 | 0.170 |
Why?
|
| Calcium Channels, L-Type | 1 | 2021 | 49 | 0.170 |
Why?
|
| Nitric Acid | 1 | 2021 | 5 | 0.170 |
Why?
|
| Genes, Recessive | 2 | 2024 | 184 | 0.170 |
Why?
|
| Cation Transport Proteins | 1 | 2021 | 99 | 0.170 |
Why?
|
| Facies | 1 | 2021 | 156 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2023 | 221 | 0.170 |
Why?
|
| Symptom Assessment | 1 | 2021 | 108 | 0.170 |
Why?
|
| Skin | 2 | 2021 | 516 | 0.170 |
Why?
|
| Genome-Wide Association Study | 2 | 2025 | 1728 | 0.170 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2020 | 12 | 0.170 |
Why?
|
| Spasms, Infantile | 1 | 2022 | 165 | 0.160 |
Why?
|
| Long QT Syndrome | 1 | 2021 | 83 | 0.160 |
Why?
|
| Homozygote | 2 | 2024 | 540 | 0.160 |
Why?
|
| Spectrin | 1 | 2021 | 70 | 0.160 |
Why?
|
| Brain Diseases | 2 | 2020 | 283 | 0.160 |
Why?
|
| Organ Transplantation | 1 | 2022 | 174 | 0.160 |
Why?
|
| RNA Splicing | 2 | 2025 | 230 | 0.160 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2020 | 9 | 0.160 |
Why?
|
| Job Syndrome | 1 | 2020 | 18 | 0.160 |
Why?
|
| Glycolysis | 1 | 2021 | 167 | 0.160 |
Why?
|
| Osteoporosis | 1 | 2021 | 132 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 3695 | 0.160 |
Why?
|
| Carrier Proteins | 4 | 2023 | 1011 | 0.160 |
Why?
|
| eIF-2 Kinase | 1 | 2020 | 35 | 0.160 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 96 | 0.160 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2020 | 78 | 0.160 |
Why?
|
| Osteoblasts | 1 | 2021 | 160 | 0.160 |
Why?
|
| Face | 2 | 2018 | 193 | 0.160 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2020 | 82 | 0.160 |
Why?
|
| Liver Function Tests | 1 | 2019 | 97 | 0.160 |
Why?
|
| Microfilament Proteins | 2 | 2021 | 269 | 0.160 |
Why?
|
| Genetic Testing | 3 | 2023 | 1056 | 0.160 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 154 | 0.150 |
Why?
|
| Chromosome Mapping | 5 | 2014 | 1054 | 0.150 |
Why?
|
| Cataract | 2 | 2024 | 142 | 0.150 |
Why?
|
| Endothelial Cells | 2 | 2023 | 501 | 0.150 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2019 | 23 | 0.150 |
Why?
|
| Nerve Degeneration | 1 | 2020 | 127 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2025 | 2746 | 0.150 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 144 | 0.150 |
Why?
|
| Amino Acids | 2 | 2020 | 615 | 0.150 |
Why?
|
| INDEL Mutation | 1 | 2019 | 91 | 0.150 |
Why?
|
| Congenital Hyperinsulinism | 1 | 2018 | 2 | 0.150 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 119 | 0.150 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2018 | 77 | 0.140 |
Why?
|
| Algorithms | 1 | 2025 | 1633 | 0.140 |
Why?
|
| Sequence Alignment | 2 | 2018 | 585 | 0.140 |
Why?
|
| Multiple Carboxylase Deficiency | 1 | 2018 | 3 | 0.140 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2019 | 107 | 0.140 |
Why?
|
| Histone Demethylases | 1 | 2018 | 37 | 0.140 |
Why?
|
| Neuroglia | 1 | 2020 | 208 | 0.140 |
Why?
|
| Urea | 1 | 2019 | 224 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 677 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 191 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 5 | 2015 | 1707 | 0.140 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 5114 | 0.130 |
Why?
|
| Hematologic Diseases | 1 | 2018 | 75 | 0.130 |
Why?
|
| Epilepsy | 2 | 2024 | 844 | 0.130 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 348 | 0.130 |
Why?
|
| Homocystinuria | 1 | 2017 | 26 | 0.130 |
Why?
|
| Vestibular Diseases | 1 | 2018 | 65 | 0.130 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2017 | 44 | 0.130 |
Why?
|
| Axons | 1 | 2020 | 373 | 0.130 |
Why?
|
| Loss of Function Mutation | 3 | 2024 | 151 | 0.130 |
Why?
|
| Disease Management | 2 | 2017 | 541 | 0.130 |
Why?
|
| Age of Onset | 2 | 2021 | 609 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 109 | 0.130 |
Why?
|
| Cohort Studies | 4 | 2024 | 4954 | 0.130 |
Why?
|
| Sexual Development | 1 | 2016 | 24 | 0.130 |
Why?
|
| Sudden Infant Death | 1 | 2016 | 32 | 0.130 |
Why?
|
| Bone Diseases, Developmental | 1 | 2016 | 60 | 0.130 |
Why?
|
| Ultrasonography | 1 | 2021 | 933 | 0.120 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2016 | 35 | 0.120 |
Why?
|
| Metalloendopeptidases | 1 | 2016 | 99 | 0.120 |
Why?
|
| Glutathione Synthase | 1 | 2016 | 4 | 0.120 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2016 | 37 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2017 | 205 | 0.120 |
Why?
|
| Macaca fascicularis | 1 | 2015 | 81 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2020 | 1194 | 0.120 |
Why?
|
| Food, Formulated | 1 | 2015 | 38 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 873 | 0.120 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 398 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2020 | 1193 | 0.120 |
Why?
|
| Protein Stability | 1 | 2015 | 162 | 0.120 |
Why?
|
| Chondrodysplasia Punctata | 1 | 2015 | 15 | 0.120 |
Why?
|
| Actins | 1 | 2017 | 311 | 0.120 |
Why?
|
| Steroid Isomerases | 1 | 2015 | 8 | 0.120 |
Why?
|
| Myosins | 1 | 2015 | 41 | 0.120 |
Why?
|
| Arthrogryposis | 1 | 2015 | 36 | 0.110 |
Why?
|
| Micronutrients | 1 | 2015 | 60 | 0.110 |
Why?
|
| Alopecia | 1 | 2015 | 40 | 0.110 |
Why?
|
| Proteolysis | 1 | 2015 | 177 | 0.110 |
Why?
|
| Crosses, Genetic | 3 | 2010 | 153 | 0.110 |
Why?
|
| Amino Acids, Essential | 1 | 2014 | 22 | 0.110 |
Why?
|
| Cell Respiration | 1 | 2014 | 24 | 0.110 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2014 | 9 | 0.110 |
Why?
|
| Neurons | 1 | 2024 | 1919 | 0.110 |
Why?
|
| Heart Defects, Congenital | 2 | 2016 | 1853 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 652 | 0.110 |
Why?
|
| Nails, Malformed | 1 | 2013 | 7 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2014 | 108 | 0.110 |
Why?
|
| Bartonella henselae | 1 | 2013 | 16 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 472 | 0.100 |
Why?
|
| Cognition | 1 | 2019 | 784 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 273 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1842 | 0.100 |
Why?
|
| Cat-Scratch Disease | 1 | 2013 | 28 | 0.100 |
Why?
|
| Homeostasis | 2 | 2011 | 689 | 0.100 |
Why?
|
| Cleidocranial Dysplasia | 1 | 2013 | 6 | 0.100 |
Why?
|
| Brachydactyly | 1 | 2013 | 10 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2015 | 585 | 0.100 |
Why?
|
| Flavoproteins | 1 | 2013 | 20 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 2883 | 0.100 |
Why?
|
| Toes | 1 | 2013 | 27 | 0.100 |
Why?
|
| Bone Development | 1 | 2013 | 54 | 0.100 |
Why?
|
| Point Mutation | 1 | 2014 | 334 | 0.100 |
Why?
|
| Internationality | 1 | 2013 | 128 | 0.100 |
Why?
|
| Sequence Deletion | 1 | 2015 | 510 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 119 | 0.100 |
Why?
|
| Exosomes | 1 | 2013 | 58 | 0.100 |
Why?
|
| Hand | 1 | 2013 | 96 | 0.090 |
Why?
|
| Phenylalanine | 1 | 2012 | 120 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1293 | 0.090 |
Why?
|
| Brain | 3 | 2022 | 3038 | 0.090 |
Why?
|
| Nucleotide Transport Proteins | 1 | 2011 | 3 | 0.090 |
Why?
|
| Infant Formula | 1 | 2012 | 104 | 0.090 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 365 | 0.090 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 748 | 0.090 |
Why?
|
| Gene Expression | 1 | 2015 | 1482 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1861 | 0.090 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 560 | 0.090 |
Why?
|
| Genetics, Population | 2 | 2020 | 184 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2015 | 550 | 0.090 |
Why?
|
| Hospitalization | 1 | 2019 | 1874 | 0.080 |
Why?
|
| Mitochondria, Liver | 1 | 2010 | 34 | 0.080 |
Why?
|
| Animals, Congenic | 1 | 2010 | 7 | 0.080 |
Why?
|
| Prognosis | 1 | 2019 | 4772 | 0.080 |
Why?
|
| Mice, Congenic | 4 | 2011 | 16 | 0.080 |
Why?
|
| Hypertension | 1 | 2018 | 1301 | 0.080 |
Why?
|
| Body Size | 1 | 2010 | 59 | 0.080 |
Why?
|
| Haploinsufficiency | 2 | 2021 | 265 | 0.080 |
Why?
|
| Weight Gain | 2 | 2010 | 377 | 0.080 |
Why?
|
| Overweight | 1 | 2012 | 370 | 0.080 |
Why?
|
| Insulin Resistance | 2 | 2011 | 665 | 0.070 |
Why?
|
| Epistasis, Genetic | 1 | 2008 | 96 | 0.070 |
Why?
|
| Sex Factors | 1 | 2012 | 1309 | 0.070 |
Why?
|
| Nitric Oxide | 2 | 2023 | 461 | 0.070 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2022 | 96 | 0.070 |
Why?
|
| Disease | 1 | 2008 | 123 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2010 | 475 | 0.070 |
Why?
|
| Drosophila melanogaster | 2 | 2025 | 808 | 0.070 |
Why?
|
| Genome | 1 | 2010 | 464 | 0.070 |
Why?
|
| Glucose | 1 | 2011 | 839 | 0.060 |
Why?
|
| Sexual Maturation | 1 | 2006 | 45 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2012 | 1654 | 0.060 |
Why?
|
| Dried Blood Spot Testing | 1 | 2025 | 26 | 0.060 |
Why?
|
| False Positive Reactions | 1 | 2025 | 133 | 0.060 |
Why?
|
| Genomics | 2 | 2023 | 1546 | 0.060 |
Why?
|
| NIMA-Related Kinases | 1 | 2024 | 13 | 0.060 |
Why?
|
| Body Weight | 4 | 2011 | 970 | 0.050 |
Why?
|
| Deafness | 1 | 2024 | 81 | 0.050 |
Why?
|
| NIH 3T3 Cells | 1 | 2023 | 92 | 0.050 |
Why?
|
| Claudins | 1 | 2023 | 30 | 0.050 |
Why?
|
| Phenylacetates | 1 | 2023 | 27 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2011 | 1352 | 0.050 |
Why?
|
| Rats | 3 | 2020 | 3390 | 0.050 |
Why?
|
| Ligases | 1 | 2023 | 34 | 0.050 |
Why?
|
| Ubiquitins | 1 | 2023 | 37 | 0.050 |
Why?
|
| Acetates | 1 | 2023 | 80 | 0.050 |
Why?
|
| Phenols | 1 | 2023 | 64 | 0.050 |
Why?
|
| Methylmalonic Acid | 1 | 2022 | 15 | 0.050 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2023 | 44 | 0.050 |
Why?
|
| Blood-Brain Barrier | 1 | 2023 | 140 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2023 | 103 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 290 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2023 | 92 | 0.050 |
Why?
|
| Multifactorial Inheritance | 1 | 2003 | 158 | 0.050 |
Why?
|
| Gait | 1 | 2023 | 143 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2003 | 100 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2025 | 4472 | 0.050 |
Why?
|
| Separase | 1 | 2022 | 28 | 0.050 |
Why?
|
| Ammonia | 1 | 2022 | 70 | 0.050 |
Why?
|
| Histidine | 1 | 2022 | 73 | 0.050 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2022 | 38 | 0.050 |
Why?
|
| Pulmonary Surfactants | 1 | 2022 | 45 | 0.050 |
Why?
|
| Nondisjunction, Genetic | 1 | 2001 | 11 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2001 | 25 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2023 | 646 | 0.040 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2021 | 25 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12546 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 70 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2001 | 58 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 90 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 415 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2021 | 113 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 137 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 2975 | 0.040 |
Why?
|
| Problem Behavior | 1 | 2021 | 39 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2025 | 3314 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2023 | 350 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 202 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2020 | 12 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2022 | 158 | 0.040 |
Why?
|
| United States | 3 | 2023 | 11310 | 0.040 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 17 | 0.040 |
Why?
|
| Mitochondria | 1 | 2025 | 730 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 132 | 0.040 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 174 | 0.040 |
Why?
|
| Time Factors | 1 | 2010 | 6134 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 2020 | 90 | 0.040 |
Why?
|
| Proteomics | 1 | 2023 | 562 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2020 | 186 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2021 | 151 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 658 | 0.040 |
Why?
|
| Folic Acid | 1 | 2001 | 277 | 0.040 |
Why?
|
| Guanosine Diphosphate Fucose | 1 | 2018 | 3 | 0.040 |
Why?
|
| Guanosine Diphosphate Mannose | 1 | 2018 | 3 | 0.040 |
Why?
|
| Glycerol | 1 | 2019 | 80 | 0.040 |
Why?
|
| Fucosyltransferases | 1 | 2018 | 25 | 0.040 |
Why?
|
| Glycosylation | 1 | 2018 | 111 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2018 | 56 | 0.040 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 89 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 160 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2023 | 683 | 0.040 |
Why?
|
| Kinetics | 1 | 2020 | 1090 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2020 | 189 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2001 | 785 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2018 | 130 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 63 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2020 | 449 | 0.030 |
Why?
|
| Models, Animal | 2 | 2011 | 452 | 0.030 |
Why?
|
| Infant Care | 1 | 2017 | 46 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 767 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2020 | 824 | 0.030 |
Why?
|
| Hydroxocobalamin | 1 | 2017 | 9 | 0.030 |
Why?
|
| White Matter | 1 | 2020 | 205 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 442 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 247 | 0.030 |
Why?
|
| Transcriptome | 1 | 2024 | 1052 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2020 | 345 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 233 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 968 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 109 | 0.030 |
Why?
|
| Sex Determination Processes | 1 | 2016 | 10 | 0.030 |
Why?
|
| Karyotype | 1 | 2016 | 29 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2021 | 821 | 0.030 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2016 | 26 | 0.030 |
Why?
|
| Gonads | 1 | 2016 | 32 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 191 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2017 | 233 | 0.030 |
Why?
|
| Aged | 1 | 2014 | 20344 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2017 | 229 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 622 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 459 | 0.030 |
Why?
|
| Drosophila | 1 | 2020 | 767 | 0.030 |
Why?
|
| Genetic Carrier Screening | 1 | 2015 | 68 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 1370 | 0.030 |
Why?
|
| Genes, X-Linked | 1 | 2015 | 60 | 0.030 |
Why?
|
| Acidosis | 1 | 2016 | 100 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2016 | 577 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 321 | 0.030 |
Why?
|
| Glutathione | 1 | 2016 | 195 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2020 | 757 | 0.030 |
Why?
|
| Cytokines | 1 | 2020 | 1320 | 0.030 |
Why?
|
| Mice, Inbred A | 2 | 2004 | 12 | 0.030 |
Why?
|
| Testis | 1 | 2016 | 405 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2015 | 162 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1516 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 2015 | 176 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 767 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2018 | 756 | 0.030 |
Why?
|
| Ovary | 1 | 2016 | 358 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 2029 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 85 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2013 | 121 | 0.030 |
Why?
|
| Child Development | 1 | 2016 | 265 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1661 | 0.030 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2013 | 25 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 276 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 2310 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2018 | 1312 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 2304 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 665 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 999 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2013 | 190 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 668 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 1377 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2013 | 401 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 90 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 2011 | 93 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3662 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2065 | 0.020 |
Why?
|
| Texas | 1 | 2017 | 3551 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2009 | 37 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 6214 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1098 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1479 | 0.020 |
Why?
|
| Adiposity | 1 | 2008 | 204 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2008 | 271 | 0.020 |
Why?
|
| Triglycerides | 1 | 2009 | 596 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1569 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2006 | 463 | 0.010 |
Why?
|
| Metabolic Syndrome | 1 | 2008 | 345 | 0.010 |
Why?
|
| Sterols | 1 | 2004 | 16 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 972 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2004 | 229 | 0.010 |
Why?
|
| Random Allocation | 1 | 2003 | 415 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 2507 | 0.010 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2001 | 7 | 0.010 |
Why?
|
| England | 1 | 2001 | 55 | 0.010 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2001 | 61 | 0.010 |
Why?
|
| Ohio | 1 | 2001 | 86 | 0.010 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2001 | 64 | 0.010 |
Why?
|
| Meiosis | 1 | 2001 | 104 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 742 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2001 | 737 | 0.010 |
Why?
|
| Anxiety | 1 | 2004 | 964 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 2001 | 454 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2003 | 2036 | 0.010 |
Why?
|
| Pregnancy | 1 | 2001 | 7373 | 0.000 |
Why?
|